Amphetamines, barbiturates, L.S.D. and cannabis : their use and misuse / [prepared by Sir Aubrey Lewis].

  • Department of Health and Social Security
Date:
1970
Catalogue details

Licence: Public Domain Mark

Credit: Amphetamines, barbiturates, L.S.D. and cannabis : their use and misuse / [prepared by Sir Aubrey Lewis]. Source: Wellcome Collection.

    60/88 (page 52)
    Greenwood, R. and Peachey, R. S., 1957. Acute amphetamine poisoning: an account of three cases. Br. med. J., i, 742. Griffith, J., 1966. A study of illicit amphetamine traffic in Oklahoma City. Am. J. Psychiat., 123, 560. Hampton, W. H., 1961. Observed psychiatric reactions following the use of amphetamine-like substances. Bull. N.Y. Acad. Med., 37, 167. Jorgensen, F. and Kodahl, T., 1961. Om ritalinmisbrug. Ugeskr. Laeg., 123, 1275. Kalant, O. J., 1966. The amphetamines: toxicity and addiction. (Brookside Monograph No. 5). Toronto, University of Toronto Press. Kramer, J. C., Fischman, V. S. and Littlefield, D. C., 1967. Amphetamine abuse: pattern and effects of high doses taken intravenously. J. Am. med. Ass., 201, 305. McConnell, W. B., 1963. Amphetamine substances in mental illnesses in Northern Ireland. Br. J. Psychiat., 109, 218. Moss, P. D., 1962. Phenmetrazine and foetal abnormalities. Br. med. J., 11, 1610. O’Flanagan, P. M. and Taylor, R. B., 1950. A case of recurrent psychosis associated with amphetamine addiction. J. ment. sci., 96, 1033. Panse, F. and Klages, W., 1964. Clinical psychopathologic observations in chronic abuse of ephedrine and related substances. Arch. Psychiat. Nerv- Krankh., 206, 69. Powell, P. D. and Johnstone, J. M., 1962. Phenmetrazine and foetal abnor- malities. Br med. J., 1, 1327. Quadbeck, G. and Schmitt, W., 1966. Klinisch-psychopathologische und tierexperimentelle Untersuchungen zur Frage der chronischen Phenmetrazin- Intoxikation. Arzneimittel-Forsch., 16, 247. Refshauge, W. D., 1963. Phenmetrazine and trifluoperazine. Med. J. Aust., i, 58. Richman, E. E., Williams, E. Y. and Brown, R. K., 1961. Acute toxic psychiatric reactions related to amphetamine medication. Med. Ann. Distr., Columbia., 30, 209. Tolentino, I. and D’Avossa, B., 1957. Psicosi da amine simpatico-mimetiche. Archo Psicol. Neurol. Psichiat., 18, 127. Weiner, I. B., 1964. Differential diagnosis in amphetamine psychosis. Psychiat. QO., 38, 707. Welsh, A. L., 1962. Side effects of anti-obesity drugs. Springfield, Thomas. World Health Organization, 1956. [Sixth report of the] Expert Committee on Drugs Liable to Produce Addiction. Tech. Rep. Ser. Wld. Hlth. Org., 102, 12. Young, G. G., Simson, C. B. and Frohman, C. E., 1961. Clinical and bio- chemical studies of an amphetamine withdrawal psychosis. J. nerv. ment. Dis., 132, 234. Zalis, E. G. and Pharmley, L. F., 1963. Fatal amphetamine poisoning. Archs intern. Med., 112, 822. Benefits and Therapeutic Use Adamson, G. T. and Finlay, S. E., 1965. The effects of two psycho-stimulant drugs on muscular performance in male athletes. Ergonomics, 8, 237. Albrinke, M. J., 1963. Obesity. In: Cecil and Loeb’s Textbook of medicine, edited by P. Beeson and W. MacDermott, London, Saunders, p. 1164. a2